Lee M. Ellis.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 8, p. 572, doi. 10.1038/nrd4085
- Publication type:
- Article
Works matching IS 14741776 AND DT 2013 AND VI 12 AND IP 8
Results: 24
1
2
Revolution dawning in cardiotoxicity testing.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 8, p. 565, doi. 10.1038/nrd4083
- By:
- Publication type:
- Article
3
Emerging paradigms in GPCR allostery: implications for drug discovery.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 8, p. 630, doi. 10.1038/nrd4052
- By:
- Publication type:
- Article
4
Isolated DNA patent ban creates muddy waters for biomarkers and natural products.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 8, p. 570, doi. 10.1038/nrd4084
- By:
- Publication type:
- Article
5
G protein-coupled receptors: Two landmark class B GPCR structures unveiled.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 8, p. 579, doi. 10.1038/nrd4082
- By:
- Publication type:
- Article
6
Therapeutic modulators of STAT signalling for human diseases.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 8, p. 611, doi. 10.1038/nrd4088
- By:
- Publication type:
- Article
7
Mood disorders: Room for improvement.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 8, p. 578, doi. 10.1038/nrd4078
- By:
- Publication type:
- Article
8
Anticancer drugs: Targeting receptor-regulator interactions.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 8, p. 580, doi. 10.1038/nrd4092
- By:
- Publication type:
- Article
9
FDA approvals for first half of 2013.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 8, p. 568, doi. 10.1038/nrd4097
- Publication type:
- Article
10
Validating therapeutic targets through human genetics.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 8, p. 581, doi. 10.1038/nrd4051
- By:
- Publication type:
- Article
11
The 'rule of three' for fragment-based drug discovery: where are we now?
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 8, p. 644, doi. 10.1038/nrd3926-c1
- By:
- Publication type:
- Article
12
Towards a prevention model of health care.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 8, p. 563, doi. 10.1038/nrd4077
- By:
- Publication type:
- Article
13
Novelty in the target landscape of the pharmaceutical industry.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 8, p. 575, doi. 10.1038/nrd4089
- By:
- Publication type:
- Article
14
In this issue.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 8, p. 561, doi. 10.1038/nrd4076
- Publication type:
- Article
15
Cancer: A new way to restore tumour suppressor function.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 8, p. 580, doi. 10.1038/nrd4093
- By:
- Publication type:
- Article
16
End of the line for PPAR modulators?
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 8, p. 568, doi. 10.1038/nrd4098
- Publication type:
- Article
17
Target profiling: Chaperones as thermodynamic sensors.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 8, p. 580, doi. 10.1038/nrd4094
- By:
- Publication type:
- Article
18
Novel therapies for hepatitis C - one pill fits all?
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 8, p. 595, doi. 10.1038/nrd4050
- By:
- Publication type:
- Article
19
Antibacterial drugs: Hitting the tuberculosis wall.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 8, p. 578, doi. 10.1038/nrd4080
- By:
- Publication type:
- Article
20
Trial Watch: Phase II and Phase III attrition rates 2011-2012.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 8, p. 569, doi. 10.1038/nrd4090
- By:
- Publication type:
- Article
21
Metabolic disease: Potassium channel blocker prevents obesity.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 8, p. 577, doi. 10.1038/nrd4081
- By:
- Publication type:
- Article
22
Dermal disorders: Boosting hair follicle regeneration.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 8, p. 580, doi. 10.1038/nrd4095
- By:
- Publication type:
- Article
23
EMA backs approval of first biosimilar monoclonal antibodies.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 8, p. 568, doi. 10.1038/nrd4096
- Publication type:
- Article
24
Influenza: Viral vector delivers protective antibodies.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 8, p. 580, doi. 10.1038/nrd4079
- By:
- Publication type:
- Article